These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

833 related items for PubMed ID: 21325951

  • 1. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N, Amano Y, Sanchez-Siles AA, Fukuhara H, Takahashi Y, Uno G, Tamagawa Y, Mishima Y, Yuki T, Ishihara S, Kinoshita Y.
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [Abstract] [Full Text] [Related]

  • 2. What is the clinical significance of stromal angiogenesis in Barrett's esophagus?
    Moriyama N, Amano Y, Mishima Y, Okita K, Takahashi Y, Yuki T, Ishimura N, Ishihara S, Kinoshita Y.
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S210-5. PubMed ID: 19120900
    [Abstract] [Full Text] [Related]

  • 3. Predictors for squamous re-epithelialization of Barrett's esophagus after endoscopic biopsy.
    Amano Y, Kushiyama Y, Yuki T, Takahashi Y, Chinuki D, Ishimura N, Furuta K, Ishihara S, Adachi K, Maruyama R, Kinoshita Y.
    J Gastroenterol Hepatol; 2007 Jun; 22(6):901-7. PubMed ID: 17565646
    [Abstract] [Full Text] [Related]

  • 4. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
    Beales IL, Ogunwobi O, Cameron E, El-Amin K, Mutungi G, Wilkinson M.
    BMC Cancer; 2007 Jun 08; 7():97. PubMed ID: 17559672
    [Abstract] [Full Text] [Related]

  • 5. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
    De Gottardi A, Dumonceau JM, Bruttin F, Vonlaufen A, Morard I, Spahr L, Rubbia-Brandt L, Frossard JL, Dinjens WN, Rabinovitch PS, Hadengue A.
    Mol Cancer; 2006 Oct 20; 5():48. PubMed ID: 17054793
    [Abstract] [Full Text] [Related]

  • 6. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR, Wild CP, Anderson LA, Murphy SJ, Johnston BT, Murray LJ, Watson RG, McGuigan J, Reynolds JV, Hardie LJ.
    Cancer Epidemiol Biomarkers Prev; 2008 Mar 20; 17(3):727-31. PubMed ID: 18349295
    [Abstract] [Full Text] [Related]

  • 7. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects.
    Majka J, Rembiasz K, Migaczewski M, Budzynski A, Ptak-Belowska A, Pabianczyk R, Urbanczyk K, Zub-Pokrowiecka A, Matlok M, Brzozowski T.
    J Physiol Pharmacol; 2010 Aug 20; 61(4):409-18. PubMed ID: 20814068
    [Abstract] [Full Text] [Related]

  • 8. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M, Kerkhof M, Steyerberg EW, Kusters JG, van Strien PM, Looman CW, van Dekken H, Siersema PD, Kuipers EJ.
    Am J Gastroenterol; 2009 Nov 20; 104(11):2673-80. PubMed ID: 19638963
    [Abstract] [Full Text] [Related]

  • 9. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ.
    Cancer Res; 2000 Oct 15; 60(20):5767-72. PubMed ID: 11059772
    [Abstract] [Full Text] [Related]

  • 10. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M, Saure C, Pahl R, Schorr F, Rüschoff J, Alles JU, Heinmöller E.
    Pathol Res Pract; 2008 Oct 15; 204(5):285-94. PubMed ID: 18337019
    [Abstract] [Full Text] [Related]

  • 11. Aurora kinase A in Barrett's carcinogenesis.
    Rugge M, Fassan M, Zaninotto G, Pizzi M, Giacomelli L, Battaglia G, Rizzetto C, Parente P, Ancona E.
    Hum Pathol; 2010 Oct 15; 41(10):1380-6. PubMed ID: 20656315
    [Abstract] [Full Text] [Related]

  • 12. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
    Abdalla SI, Lao-Sirieix P, Novelli MR, Lovat LB, Sanderson IR, Fitzgerald RC.
    Clin Cancer Res; 2004 Jul 15; 10(14):4784-92. PubMed ID: 15269153
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.
    Wilson KT, Fu S, Ramanujam KS, Meltzer SJ.
    Cancer Res; 1998 Jul 15; 58(14):2929-34. PubMed ID: 9679948
    [Abstract] [Full Text] [Related]

  • 14. Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus.
    Dvorak K, Chavarria M, Payne CM, Ramsey L, Crowley-Weber C, Dvorakova B, Dvorak B, Bernstein H, Holubec H, Sampliner RE, Bernstein C, Prasad A, Green SB, Garewal H.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5305-13. PubMed ID: 17875759
    [Abstract] [Full Text] [Related]

  • 15. Preferential up-regulation of heparanase and cyclooxygenase-2 in carcinogenesis of Barrett's oesophagus and intestinal-type gastric carcinoma.
    Sonoda R, Naomoto Y, Shirakawa Y, Fujiwara Y, Yamatsuji T, Noma K, Tanabe S, Takaoka M, Gunduz M, Tsujigiwa H, Nagatsuka H, Ohara N, Yoshino T, Takubo K, Vieth M, Tanaka N.
    Histopathology; 2010 Jul 15; 57(1):90-100. PubMed ID: 20653782
    [Abstract] [Full Text] [Related]

  • 16. Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure.
    Hao Y, Sood S, Triadafilopoulos G, Kim JH, Wang Z, Sahbaie P, Omary MB, Lowe AW.
    BMC Gastroenterol; 2007 Jun 27; 7():24. PubMed ID: 17597535
    [Abstract] [Full Text] [Related]

  • 17. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.
    Morris CD, Armstrong GR, Bigley G, Green H, Attwood SE.
    Am J Gastroenterol; 2001 Apr 27; 96(4):990-6. PubMed ID: 11316217
    [Abstract] [Full Text] [Related]

  • 18. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia.
    Inge LJ, Fowler AJ, Paquette KM, Richer AL, Tran N, Bremner RM.
    J Thorac Cardiovasc Surg; 2013 Feb 27; 145(2):531-8. PubMed ID: 23142123
    [Abstract] [Full Text] [Related]

  • 19. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
    Weston AP, Badr AS, Hassanein RS.
    Am J Gastroenterol; 1999 Dec 27; 94(12):3413-9. PubMed ID: 10606296
    [Abstract] [Full Text] [Related]

  • 20. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus.
    Halm U, Tannapfel A, Breitung B, Breidert M, Wittekind CW, Mössner J.
    Hepatogastroenterology; 2000 Dec 27; 47(34):962-6. PubMed ID: 11020858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.